Related references
Note: Only part of the references are listed.Intestinal differentiation involves cleavage of histone H3 N-terminal tails by multiple proteases
Karin Johanna Ferrari et al.
NUCLEIC ACIDS RESEARCH (2021)
IκBα targeting promotes oxidative stress-dependent cell death
Giovanna Carra et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
Single loss of a Trp53 allele triggers an increased oxidative, DNA damage and cytokine inflammatory responses through deregulation of IκBα expression
Laura Marruecos et al.
CELL DEATH & DISEASE (2021)
The dark side of histones: genomic organization and role of oncohistones in cancer
Stefano Amatori et al.
CLINICAL EPIGENETICS (2021)
NF-κB dynamics determine the stimulus specificity of epigenomic reprogramming in macrophages
Quen J. Chen et al.
SCIENCE (2021)
IκBα deficiency imposes a fetal phenotype to intestinal stem cells
Laura Marruecos et al.
EMBO REPORTS (2020)
EZH2-Targeted Therapies in Cancer: Hype or a Reality
Marie-Lisa Eich et al.
CANCER RESEARCH (2020)
Ancestral function ofInhibitors-of-kappaB regulates Caenorhabditis elegans development
David Brena et al.
SCIENTIFIC REPORTS (2020)
Activation of NF-κB in B cell receptor signaling through Bruton's tyrosine kinase-dependent phosphorylation of IκB-α
Marilena Pontoriero et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2019)
The expanding landscape of 'oncohistone' mutations in human cancers
Benjamin A. Nacev et al.
NATURE (2019)
A Case of Identity: HOX Genes in Normal and Cancer Stem Cells
Jessica Smith et al.
CANCERS (2019)
Mutational Landscape of Grey Zone Lymphoma
Clementine Sarkozy et al.
BLOOD (2019)
Role of HOX Genes in Stem Cell Differentiation and Cancer
Seema Bhatlekar et al.
STEM CELLS INTERNATIONAL (2018)
Association of NFKB1 and NFKBIA gene polymorphisms with susceptibility of gastric cancer
Dan Li et al.
TUMOR BIOLOGY (2017)
Exome and genome sequencing of nasopharynx cancer identifies NF-κB pathway activating mutations
Yvonne Y. Li et al.
NATURE COMMUNICATIONS (2017)
IKBB tumor suppressive role in nasopharyngeal carcinoma via NF-B-mediated signalling
Yee Peng Phoon et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
The non-genomic loss of function of tumor suppressors: an essential role in the pathogenesis of chronic myeloid leukemia chronic phase
Sabrina Crivellaro et al.
BMC CANCER (2016)
Persistent Activation of NF-κB in BRCA1-Deficient Mammary Progenitors Drives Aberrant Proliferation and Accumulation of DNA Damage
Andrea Sau et al.
CELL STEM CELL (2016)
PRC2 preserves intestinal progenitors and restricts secretory lineage commitment
Fulvio Chiacchiera et al.
EMBO JOURNAL (2016)
Deletion of Polycomb Repressive Complex 2 From Mouse Intestine Causes Loss of Stem Cells
Martijn A. J. Koppens et al.
GASTROENTEROLOGY (2016)
Predictive and prognostic value of TLR9 and NFKBIA gene expression as potential biomarkers for human glioma diagnosis
Ata Miyar et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2016)
Whole-exome sequencing identifies multiple loss-of-function mutations of NF-κB pathway regulators in nasopharyngeal carcinoma
Hong Zheng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Deletion and low expression of NFKBIA are associated with poor prognosis in lower-grade glioma patients
Gabriela Sarti Kinker et al.
SCIENTIFIC REPORTS (2016)
Polymorphisms in NFKB1 and NFKBIA Genes Modulate the Risk of Developing Prostate Cancer among Han Chinese
Zi-an Wang
MEDICAL SCIENCE MONITOR (2015)
Identification of a NFKBIA polymorphism associated with lower NFKBIA protein levels and poor survival outcomes in patients with glioblastoma multiforme
Zhaohui Zhao et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2014)
Recombinant IκBα-loaded curcumin nanoparticles for improved cancer therapeutics
Subhamoy Banerjee et al.
NANOTECHNOLOGY (2014)
Improved vectors and genome-wide libraries for CRISPR screening
Neville E. Sanjana et al.
NATURE METHODS (2014)
Chromatin-Bound IκBα Regulates a Subset of Polycomb Target Genes in Differentiation and Cancer
Maria Carmen Mulero et al.
CANCER CELL (2013)
A Truncated Form of IKKα Is Responsible for Specific Nuclear IKK Activity in Colorectal Cancer
Pol Margalef et al.
CELL REPORTS (2012)
FAS and NF-κB signalling modulate dependence of lung cancers on mutant EGFR
Trever G. Bivona et al.
NATURE (2011)
NFKBIA Deletion in Glioblastomas.
Markus Bredel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
NF-κB addiction and its role in cancer: 'one size does not fit all'
M. M. Chaturvedi et al.
ONCOGENE (2011)
Mechanism of Hypoxia-Induced NF-κB
Carolyn Culver et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
The mutation spectrum revealed by paired genome sequences from a lung cancer patient
William Lee et al.
NATURE (2010)
Polymorphisms in NF-κB Inhibitors and Risk of Epithelial Ovarian Cancer
Kristin L. White et al.
BMC CANCER (2009)
IkappaBalpha gene promoter polymorphisms are associated with hepatocarcinogenesis in patients infected with hepatitis B virus genotype C
Yongchao He et al.
CARCINOGENESIS (2009)
OPINION Is NF-κB a good target for cancer therapy? Hopes and pitfalls
Veronique Baud et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Nuclear factor-κB activation and differential expression of survivin and Bcl-2 in human grade 2-4 astrocytomas
Filippo F. Angileri et al.
CANCER (2008)
A novel mutation in NFKBIA/IKBA results in a degradation-resistant N-truncated protein and is associated with ectodermal dysplasia with immunodeficiency
Eduardo Lopez Granados et al.
HUMAN MUTATION (2008)
Expression of nuclear factor-κB in human astrocytomas:: relation to pIκBa, vascular endothelial growth factor, Cox-2, microvascular characteristics, and survival
Penelope Korkolopoulou et al.
HUMAN PATHOLOGY (2008)
Epidermal growth factor (EGF) activates nuclear factor-κB through IκBα kinase-independent but EGF receptor-kinase dependent tyrosine 42 phosphorylation of IκBα
G. Sethi et al.
ONCOGENE (2007)
Importance of polymorphisms in NF-κB1 and NF-κBIα genes for melanoma risk, clinicopathological features and tumor progression in Swedish melanoma patients
Huajie Bu et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2007)
NF-κB is a negative regulator of IL-1β secretion as revealed by genetic and pharmacological inhibition of IKKβ
Florian R. Greten et al.
CELL (2007)
Association of NFKBIA polymorphism with colorectal cancer risk and prognosis in Swedish and Chinese populations
Jingfang Gao et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2007)
Haplotypic structure across the IκBα gene (NFKB1A) and association with multiple myeloma
Charlotte F. Spink et al.
CANCER LETTERS (2007)
Nuclear IKK activity leads to dysregulated Notch-dependent gene expression in colorectal cancer
V. Fernandez-Majada et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Polymorphism in the promoter region of the NFKB1 gene increases the risk of sporadic colorectal cancer in Swedish but not in Chinese populations
Andreas Lewander et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2007)
Nuclear factor-κB (NF-κB) is frequently expressed in lung cancer and preneoplastic lesions
Ximing Tang et al.
CANCER (2006)
Lack of IKBA coding region mutations in primary mediastinal large B-cell lymphoma and the host response subtype of diffuse large B-cell lymphoma
H Takahashi et al.
BLOOD (2006)
Activation of nuclear factor-κB in human prostate carcinogenesis and association to biochemical relapse
J Domingo-Domenech et al.
BRITISH JOURNAL OF CANCER (2005)
Expression of nuclear factor-κB and IκBα proteins in prostatic adenocarcinomas:: Correlation of nuclear factor-κB immunoreactivity with disease recurrence
JS Ross et al.
CLINICAL CANCER RESEARCH (2004)
Nuclear factor-κB is an important modulator of the altered gene expression profile and malignant phenotype in squamous cell carcinoma
A Loercher et al.
CANCER RESEARCH (2004)
Mutational analysis of the IκBα gene in activated B cell-like diffuse large B-cell lymphoma
RK Thomas et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
Recruitment of IκBα to the hes1 promoter is associated with transcriptional repression
C Aguilera et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Cytoplasmic IκBα increases NF-κB-independent transcription through binding to histone deacetylase (HDAC) 1 and HDAC3
P Viatour et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Transfection of a dominant-negative mutant NF-κB inhibitor (IkBm) represses p53-dependent apoptosis in acute lymphoblastic leukemia cells:: interaction of IkBm and p53
MX Zhou et al.
ONCOGENE (2003)
Hydrogen peroxide activates NF-κB through tyrosine phosphorylation of IκBα and serine phosphorylation of p65 -: Evidence for the involvement of IκBα kinase and Syk protein-tyrosine kinase
Y Takada et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The proteasome inhibitor PS-341 potentiates sensitivity of multiple myeloma cells to conventional chemotherapeutic agents: therapeutic applications
N Mitsiades et al.
BLOOD (2003)
NF-κB blockade and oncogenic Ras trigger invasive human epidermal neoplasia
M Dajee et al.
NATURE (2003)
The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma
KJ Savage et al.
BLOOD (2003)
The human B-cell lymphoma cell line RC-K8 has multiple genetic alterations that dysregulate the Rel/NF-κB signal transduction pathway
D Kalaitzidis et al.
ONCOGENE (2002)
Identification of polymorphisms of the IκBα gene associated with an increased risk of multiple myeloma
KM Parker et al.
CANCER GENETICS AND CYTOGENETICS (2002)
Genomic organization and expression of the rearranged REL proto-onicogene in the human B-cell lymphoma cell line RC-K8
D Kalaitzidis et al.
GENES CHROMOSOMES & CANCER (2002)
Tyrosine phosphorylation-dependent activation of NF-κB -: Requirement for p56 LCK and ZAP-70 protein tyrosine kinases
A Livolsi et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2001)
Pervanadate-induced nuclear factor-κB activation requires tyrosine phosphorylation and degradation of IκBα -: Comparison with tumor necrosis factor-α
A Mukhopadhyay et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Clonal deleterious mutations in the IκBα gene in the malignant cells in Hodgkin's lymphoma
B Jungnickel et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Share Paper
